Ovarian Cancer

Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.

Overview

Feature Articles

Latest Ovarian Cancer News and Research

New type of immunotherapy effective in mice with ovarian cancer

New type of immunotherapy effective in mice with ovarian cancer

Higher consumption of ultra-processed foods associated with greater risk of developing cancer

Higher consumption of ultra-processed foods associated with greater risk of developing cancer

Loyalty card data on over-the-counter drug purchases could help spot ovarian cancer cases earlier

Loyalty card data on over-the-counter drug purchases could help spot ovarian cancer cases earlier

Lifetime ovulatory years positively associated with epithelial ovarian cancer

Lifetime ovulatory years positively associated with epithelial ovarian cancer

Boosting nutritional knowledge with the help of a dietitian specializing in cancer

Boosting nutritional knowledge with the help of a dietitian specializing in cancer

Early tastings allow infants to eat more food and stop breastfeeding

Early tastings allow infants to eat more food and stop breastfeeding

Cancer mortality in the U.S. has declined 33% since the 90s

Cancer mortality in the U.S. has declined 33% since the 90s

New genetic test could guide the treatment of ovarian cancer

New genetic test could guide the treatment of ovarian cancer

Using machine learning models to guide the design of long-acting injectable drug formulations

Using machine learning models to guide the design of long-acting injectable drug formulations

Novel T cell receptor therapy shows early promise for treating solid tumors

Novel T cell receptor therapy shows early promise for treating solid tumors

Clinically relevant biomarker strategies in drug development

Clinically relevant biomarker strategies in drug development

High affinity antibodies isolated to safely target Claudin 6-positive tumors

High affinity antibodies isolated to safely target Claudin 6-positive tumors

New imaging agent lights the way for surgeons during lung cancer surgery

New imaging agent lights the way for surgeons during lung cancer surgery

FDA approves targeted imaging agent for use in lung cancer surgery

FDA approves targeted imaging agent for use in lung cancer surgery

Genetic testing program could help to close the gap for some patients with prostate cancer

Genetic testing program could help to close the gap for some patients with prostate cancer

The business of clinical trials is booming. Private equity has taken notice.

The business of clinical trials is booming. Private equity has taken notice.

The importance of early cancer screening

The importance of early cancer screening

New machine learning fusion model for better diagnosis of ovarian lesions

New machine learning fusion model for better diagnosis of ovarian lesions

Deep learning model uses a single chest X-ray to predict heart disease risk

Deep learning model uses a single chest X-ray to predict heart disease risk